U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C8H16N2O4S2
Molecular Weight 268.354
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HOMOCYSTINE, L-

SMILES

N[C@@H](CCSSCC[C@H](N)C(O)=O)C(O)=O

InChI

InChIKey=ZTVZLYBCZNMWCF-WDSKDSINSA-N
InChI=1S/C8H16N2O4S2/c9-5(7(11)12)1-3-15-16-4-2-6(10)8(13)14/h5-6H,1-4,9-10H2,(H,11,12)(H,13,14)/t5-,6-/m0/s1

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Importance of the trans-sulfuration pathway in cancer prevention and promotion.
2007-07
Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase.
2007-05
Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke.
2007-04-30
A rationale for cystine supplementation in severe homocystinuria.
2007-02
Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis.
2007-01
Thermolabile methylenetetrahydrofolate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population.
2007
Differential effects of endogenous cysteine analogs on peripheral thermal nociception in intact rats.
2006-11
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.
2006-09-26
The screening power of methylenetetrahydrofolate reductase C677T polymorphism versus plasma homocysteine concentration in patients with stenosis of the internal carotid artery.
2006-09-25
A new method for determination of plasma homocystine by isotope dilution and electrospray tandem mass spectrometry.
2006-09-14
Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus.
2006-07
California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting.
2006-06-30
Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
2006-04
Homocysteine transport by human aortic endothelial cells: identification and properties of import systems.
2006-02-15
Homocyst(e)ine and stroke.
2006-02
Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies.
2006-01-23
Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk.
2006-01-11
Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes.
2005-11-07
Workgroup report: Biomonitoring study design, interpretation, and communication--lessons learned and path forward.
2005-11
Fibrinogen, homocyst(e)ine, and C-reactive protein concentrations relative to sex and socioeconomic status in British young people.
2005-10-29
Homocyst(e)ine-lowering therapy does not affect plasma asymmetrical dimethylarginine concentrations in patients with peripheral artery disease.
2005-04
Aleurone flour increases red-cell folate and lowers plasma homocyst(e)ine substantially in man.
2005-03
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.
2005-02
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
2005-02
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
2005
Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis.
2005
Inflammation causes tissue-specific depletion of vitamin B6.
2005
Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
2005
High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells.
2004-11
Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.
2004-10-16
The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.
2004-09-07
[A case of young adult presenting with cerebral infarction caused by homocystinuria].
2004-09
Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation.
2004-05-10
Methylenetetrahydrofolate reductase 677 C-->T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women.
2004-05
Long-term treatment with probucol improves endothelial function in patients with coronary artery disease.
2004-05
[Prevention of dementia (including Alzheimer's disease)].
2004-05
The C677 mutation in methylene tetrahydrofolate reductase gene: correlation with uric acid and cardiovascular risk factors in elderly Korean men.
2004-04
Folic acid improves endothelial function in children and adolescents with type 1 diabetes.
2004-04
L-Homocysteine and L-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cells.
2004-03-01
Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications.
2004-02-17
Comparing the ESA HPLC total homocysteine assay with electrochemical detection to the CDC in-house HPLC assay with fluorescence detection.
2004-02
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
2003-08-26
Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey.
2003-08-05
Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice.
2003-06
Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification.
2003-06
Association between homocyst(e)ine levels and risk of vascular events.
2003-03
Study of total homocyst(e)ine levels in type 2 diabetic patients with silent brain infarction.
2003
2 minute non-invasive screening for cardio-vascular diseases: relative limitation of C-Reactive Protein compared with more sensitive L-Homocystine as cardio-vascular risk factors; safe and effective treatment using the selective drug uptake enhancement method.
2003
Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness.
2003
Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
2001
Patents
Name Type Language
BUTANOIC ACID, 4,4'-DITHIOBIS(2-AMINO-, (2S,2'S)-
Preferred Name English
HOMOCYSTINE, L-
Systematic Name English
HOMOCYSTINE
Systematic Name English
HOMOCYSTINE, (+)-
Systematic Name English
BUTYRIC ACID, 4,4'-DITHIOBIS(2-AMINO-, L-
Common Name English
L-HOMOCYSTINE [MI]
Common Name English
BUTANOIC ACID, 4,4'-DITHIOBIS(2-AMINO-, (S-(R*,R*))-
Common Name English
Classification Tree Code System Code
LOINC 55879-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 30051-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 26809-4
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 20646-6
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 2431-5
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 54302-5
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 25441-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 13399-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 26882-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 27352-4
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 26999-3
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 16711-4
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
CFR 21 CFR 862.1377
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 15135-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 2429-9
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 22660-5
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 22715-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 2430-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 22673-8
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 25929-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 56682-8
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 22707-4
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 14053-3
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 13759-6
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 38486-7
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 44720-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 13372-8
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 25928-3
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 44378-8
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 6884-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
LOINC 15143-1
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
Code System Code Type Description
CAS
626-72-2
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-323-8
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
ALTERNATIVE
ECHA (EC/EINECS)
210-962-5
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
FDA UNII
804AS222UE
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
MERCK INDEX
m6043
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
Homocystine
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
EPA CompTox
DTXSID001019905
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
MESH
D006711
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
CHEBI
17485
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY
PUBCHEM
439579
Created by admin on Mon Mar 31 17:50:26 GMT 2025 , Edited by admin on Mon Mar 31 17:50:26 GMT 2025
PRIMARY